Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with clinical outcome in recurrent or metastatic head and neck cancer patients treated with nivolumab
暂无分享,去创建一个
M. Takumida | T. Hamamoto | Nobuyuki Chikuie | S. Takeno | T. Ishino | T. Ueda | Takashi Kono | T. Taruya | H. Furuie | Minoru Hattori | N. Chikuie | T. Kono | M. Hattori